TABLE 5.
Traditional Chinese medicine symptom disappearance rate in different groups
| Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| Symptoms | Pidotimod | YPF | Placeco | χ2 | P | P1 † | P2 ‡ | P3 § |
| Aversion to wind | 58 (51.79) | 74 (67.89) | 22 (40.00) | 12.7583 | 0.0017 | 0.0147 | 0.1519 | 0.0006 |
| Spontaneous sweating | 59 (43.38) | 77 (58.33) | 23 (34.85) | 11.3692 | 0.0034 | 0.0144 | 0.2467 | 0.0018 |
| Shortness of breath | 50 (60.24) | 52 (63.41) | 15 (39.47) | 6.4858 | 0.0391 | 0.6748 | 0.0335 | 0.0140 |
| Pale complexion | 70 (63.64) | 68 (66.67) | 24 (42.11) | 10.1136 | 0.0064 | 0.6437 | 0.0078 | 0.0026 |
| Weak breathing and lasy to talk | 26 (38.81) | 31 (43.06) | 10 (25.00) | 3.6659 | 0.1599 | / | / | / |
| Poor appetite | 57 (61.96) | 55 (63.22) | 16 (39.02) | 7.6303 | 0.0220 | 0.8616 | 0.0141 | 0.0102 |
| Thinness | 26 (53.06) | 23 (56.10) | 10 (40.00) | 1.7163 | 0.4239 | / | / | / |
| Sloppy stool | 35 (77.78) | 41 (89.13) | 13 (50.00) | 14.0892 | 0.0009 | 0.1445 | 0.0160 | 0.0002 |
Data are shown as n (%). YPF, Yupingfeng. Disappearance rate = proportion of symptom‐free patients after treatment to those with such symptoms at baseline.
†
Pidotimod group vs. YPF group; ‡Pidotimod group vs. Placebo group; §YPF group vs. Placebo group.